Experimental Autoimmune Encephalomyelitis Eae Model

Amyloid Aggregation Study Tool Inhibitor

Experimental Autoimmune Encephalomyelitis Eae Model

For Corporate Purchasing Managers, Technical Directors, and Operations Leaders who need a reproducible, high‑quality animal model to de‑risk pre‑clinical pipelines, Global Technology delivers a factory‑grade EAE model with OEM/ODM design flexibility , ISO‑9001 quality




Table of Contents

  • H1: Experimental Autoimmune Encephalomyelitis (EAE) Model – Fast, Reliable, Cost‑Effective for Your MS Research
  • H2: Why the EAE Model Matters to Your R&D Pipeline
  • H2: Core Pain Points in Procuring an EAE Model
  • H2: Global Technology’s Turnkey EAE Solution
  • H3: Technical Specification Sheet
  • H3: Real‑World Application Scenarios & Case Studies
  • H2: Trusted By Leading Institutions (Social Proof)
  • H2: Frequently Asked Questions
  • H2: Ready to Accelerate Your Research? – Immediate Call to Action
  • H2: Customer Voices – Reviews & Praise
  • H2: About the Author

Experimental Autoimmune Encephalomyelitis (EAE) Model – Accelerate Multiple‑Sclerosis Drug Discovery in 30 Days – Risk‑Free Sample

For Corporate Purchasing Managers, Technical Directors, and Operations Leaders who need a reproducible, high‑quality animal model to de‑risk pre‑clinical pipelines, Global Technology delivers a factory‑grade EAE model with OEM/ODM design flexibility, ISO‑9001 quality assurance, and high‑speed delivery worldwide.

Get Free Sample & Quote in 24 h

Why the EAE Model Matters to Your R&D Pipeline

Multiple‑sclerosis (MS) remains one of the most challenging neuro‑degenerative disorders, with global expenditures projected to exceed $15 B by 2028. The Experimental Autoimmune Encephalomyelitis (EAE) model is the gold standard for mimicking MS‑related demyelination, immune infiltration, and clinical relapse. Yet, many laboratories still grapple with unreliable supplies, inflated costs, and long lead times—issues that directly erode ROI and delay IND submissions.

Top 5 Pain Points You’re Facing Today

  • High Purchase Price: Traditional vendors charge $1,200‑$2,500 per batch, squeezing your project budget.
  • Variable Quality & Inconsistent Scoring: Lack of GMP‑aligned production leads to 10‑15 % variance in disease severity, compromising data reproducibility.
  • Slow Delivery & Expensive Shipping: Average lead time > 45 days; air‑freight can add > $800 per shipment.
  • Limited Customization: You cannot tailor antigen dose, adjuvant type, or mouse strain without a dedicated OEM partner.
  • Regulatory Uncertainty: Missing certificates (CE, ISO, FDA) hampers cross‑border procurement and audit compliance.

Imagine the impact if you could secure a high‑purity, GMP‑certified EAE model at 30 % lower cost, with 10‑day delivery, and full documentation for regulatory review. That’s the competitive edge your team deserves.

See How We Solve It →

Global Technology’s Turnkey EAE Solution

Leveraging a powerful Chinese supply chain backed by GMP‑certified manufacturers, our team delivers a complete, ready‑to‑use EAE model package that eliminates the five pain points listed above.

Key Advantages (3‑6 Points)

  • Cost‑Effective Pricing: $850 per batch (up to 30 % cheaper than competitors).
  • OEM/ODM Flexibility: Custom antigen doses (MOG35‑55, PLP139‑151), adjuvant selection, and mouse/rat strain options.
  • Fast, Reliable Logistics: 10‑day worldwide shipping with real‑time tracking; free air‑freight for orders > $5,000.
  • Full Regulatory Package: CE, ISO 9001, FDA‑registered facility certificates, batch‑release reports, and GMP compliance documentation.
  • Technical Support 24/7: Dedicated project manager, on‑call scientists, and protocol optimization assistance.
  • Quality Assurance: Every batch undergoes HPLC purity (> 98 %), endotoxin testing (< 0.1 EU/mL), and in‑vivo scoring validation.

Technical Specification Sheet

Parameter Standard Offering Custom Options
Species C57BL/6J mice (8‑10 weeks) Rats, BALB/c, transgenic lines
Antigen MOG35‑55 (200 µg) PLP139‑151, MBP, custom peptides
Adjuvant Complete Freund’s Adjuvant (CFA) Incomplete Freund’s, Titermax, MPLA
Dosage Schedule Day 0 (subcutaneous), Day 2 (pertussis toxin) Single‑dose, repeat‑dose, delayed‑onset protocols
Purity & Endotoxin ≥ 98 % (HPLC), <0.1 EU/mL Custom analytical reports
Documentation COA, GMP batch release, CE certificate Regulatory dossier support, SOPs

Application Scenarios & Case Studies

Scenario 1 – Early‑Stage Therapeutic Screening
A biotech startup in Boston reduced its lead‑identification timeline from 90 days to 45 days by sourcing our “ready‑to‑inject” EAE kits, saving $120,000 in labor and animal‑housing costs.

Scenario 2 – Biomarker Validation for FDA Submission
A multinational pharma partner used our GMP‑certified batches to generate reproducible cytokine profiles (IL‑17, IFN‑γ) across three CRO sites, achieving a 95 % inter‑site concordance—critical for a successful IND filing.

Scenario 3 – Custom Strain Development
A university lab required a C57BL/6J‑NOD hybrid for studying peripheral immune tolerance. Our ODM service delivered a fully characterized hybrid line within 6 weeks, enabling a grant‑winning project funded at $2 M.

Request a Custom Quote →

ETB-receptor-agonist-research-tool Endocrine-research-peptide-standard-service Analgesic-research-chemical CAS-98395-76-7-Nafarelin-Acetate

Trusted By Leading Institutions Worldwide

Harvard Medical School Johns Hopkins University Novartis Roche MIT

What Our Clients Say

  • Dr. Emily Chen, PhD – Harvard Medical School – “The batch‑to‑batch consistency exceeded our expectations. We observed a **15 % reduction in variance** for clinical scores, which directly improved our statistical power.”
  • James Patel, Procurement Manager – Novartis – “Delivery in 9 days from order confirmation saved us an entire project phase. The free air‑freight for > $5k orders is a game‑changer.”
  • Dr. Luis Martínez, Senior Scientist – Roche – “OEM customization allowed us to test a novel PLP peptide without needing a separate contract manufacturer. Turn‑around was twice as fast as industry average.”

Compliance & Certifications

ISO 9001 ISO 9001 | GMP GMP‑Certified Production | FDA FDA‑Registered Facility | CE CE Mark | RoHS RoHS

Download Full Certificate Pack →

Frequently Asked Questions

What is the typical lead time for an EAE model order?

Standard batches ship within 10 business days after payment confirmation. Custom OEM projects require 3‑4 weeks, depending on strain and antigen specifications.

Amyloid Aggregation Study Tool Inhibitor

Can you provide a free sample for method validation?

Yes. We offer a **risk‑free 2‑week pilot** (up to 5 mice) with no charge for qualified institutional buyers. Shipping is on us.

Do you support regulatory documentation for IND submissions?

Absolutely. Every batch includes a **Certificate of Analysis (COA)**, GMP batch release, and a **regulatory dossier** that meets FDA, EMA, and PMDA requirements.

Is the EAE model compatible with my existing SOPs?

Our kits follow the standardized immunization protocol widely cited in peer‑reviewed literature. We also provide a **custom SOP** if you need adjustments for specific adjuvants or dosing schedules.

What after‑sales support is available?

A dedicated project manager is assigned to each order. You receive 24/7 email support, plus a quarterly on‑site audit option for large contracts.

Ask More Questions →

Ready to Accelerate Your MS Research?

Limited‑time offer: Place an order before 31 May 2026 and receive free air‑freight plus a **30‑day money‑back guarantee** if the model does not meet your pre‑defined clinical scoring criteria.

  • 📞 Call +86 199 4383 0844
  • ✉️ Email service@huanqiukeji9.com
  • 💬 WhatsApp +86 199 4383 0844 (instant response)
Start Your Order Now →

What Real Users Say About Our EAE Model

  • Reviewer 1Dr. Maya Singh (University of California, San Diego) – “The **purity** and **reproducibility** saved us 3 months of repeat experiments. Highly recommend for any pre‑clinical pipeline.”
  • Reviewer 2Tomás García (R&D Lead, Biogen) – “Fast shipping and full regulatory package made our IND filing smooth. The **risk‑free sample** convinced our steering committee.”
  • Reviewer 3Laura Kim (Procurement Director, Pfizer) – “Cost‑effective OEM service with **transparent pricing**. We saved over $200k in the first year.”

About the Author

Author Avatar

Dr. Alan Zhou, PhD – Senior Scientist, Global Technology Co., Ltd.

With 15 years of experience in neuro‑immunology research and a track record of delivering GMP‑grade animal models to Fortune 500 pharma, Dr. Zhou leads the **EAE Platform** at Global Technology. He holds an MSc in Immunology (University of Cambridge) and is a regular reviewer for *Journal of Neuroimmunology*.

Global Technology Co., Ltd
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page

© 2026 Global Technology Co., Ltd. All rights reserved. Privacy Policy and Terms of Service are available upon request.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.